Vital-IT Computational Biology | SIB Swiss Institute of Bioinformatics
Distillerie Grafiche – Malted Web and Graphic Design – Swiss Westlands
Distillerie Grafiche – Malted Web and Graphic Design – Swiss Westlands
Type 2 diabetes currently impacts the lives of some 400 million people worldwide. It is already considered as a global epidemic due to the constant increase in the number of patients and the challenges faced by families, partners and caregivers.
As supported by the World Health Organisation , “effective measures for the surveillance, prevention and control of diabetes and its complications” need be developed. This is where RHAPSODY came in.
Currently, risk and diagnosis of type 2 diabetes are confirmed by testing blood sugar levels. Hence, blood glucose acts as a ‘biomarker’ for the risk and presence of diabetes. In RHAPSODY, it is our aim to identify novel biomarkers, other than blood glucose, that can be used to identify individuals most at risk of developing type 2 diabetes, and predict its individual clinical course (disease progression) and its complications.
Vital-IT Computational Biology | SIB Swiss Institute of Bioinformatics
Distillerie Grafiche – Malted Web and Graphic Design – Swiss Westlands
Distillerie Grafiche – Malted Web and Graphic Design – Swiss Westlands